Results 211 to 220 of about 210,178 (301)
Recurrent and De Novo Cirrhosis After Liver Transplantation. [PDF]
Rao AK, Rockey DC.
europepmc +1 more source
ABSTRACT Background and Aims Patients with chronic hepatitis C and advanced fibrosis remain at substantial risk of hepatocellular carcinoma (HCC) and non‐liver–related death even after sustained virological response (SVR) to direct‐acting antivirals (DAA).
Daisuke Sakon +19 more
wiley +1 more source
Awareness of Hepatitis C Test Results Among Reported Cases in Los Angeles County, 2021-2022. [PDF]
Bhardwaj LN +6 more
europepmc +1 more source
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma +7 more
wiley +1 more source
Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern. [PDF]
Aksak-Wąs B +10 more
europepmc +1 more source
Human Cortical Neural Progenitor Cells
Cell Proliferation, EarlyView.
An‐Xin Wang +29 more
wiley +1 more source
Many patients with chronic liver disease can safely avoid unnecessary screening endoscopy using the Baveno VII criteria. We developed a simple three‐factor score to identify patients at high risk of serious esophageal varices. Using both approaches together may improve the efficiency and safety of endoscopic screening.
Maiko Asami +9 more
wiley +1 more source
Integrated Studies of Infectious Disease Elimination (InSIDE): Hepatitis C Antibody and RNA Status of Persons Who Inject Drugs in New York State, 2021-2023. [PDF]
Barranco MA +4 more
europepmc +1 more source
Olaparib‐associated cutaneous vasculitis in a patient with breast cancer
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcial Álvarez‐Salafranca +3 more
wiley +1 more source
Although the number of HCV antibody‐positive patients in ophthalmology departments has decreased, the proportion requiring referral for DAA therapy has not declined despite the widespread use of DAAs. Furthermore, combining HCV antibody titer determination with EMR review improves the efficiency of identifying patients requiring referral.
Ritsuzo Kozuka +21 more
wiley +1 more source

